SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-012568
Filing Date
2024-04-19
Accepted
2024-04-19 16:37:08
Documents
14
Period of Report
2024-04-19
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20240418_8k.htm   iXBRL 8-K 26027
  Complete submission text file 0001437749-24-012568.txt   158075

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tlph-20240419.xsd EX-101.SCH 3410
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlph-20240419_def.xml EX-101.DEF 11425
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlph-20240419_lab.xml EX-101.LAB 15311
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlph-20240419_pre.xml EX-101.PRE 11585
17 EXTRACTED XBRL INSTANCE DOCUMENT acrx20240418_8k_htm.xml XML 2828
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 24858298
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)